TABLE 1.
Patient characteristics of two groups
| Characteristic | Targeted therapy + SS | Targeted therapy |
|---|---|---|
| Total patients | N = 18 | N = 73 |
| Gender | ||
| Male | 9 | 27 |
| Female | 9 | 46 |
| Age, years | ||
| Median | 54 | 58 |
| Range | 32–67 | 35–77 |
| Smoking history | ||
| Never | 13 | 55 |
| Active/former | 5 | 18 |
| Mutation type | ||
| Exon 19 deletion | 11 | 49 |
| L858R | 5 | 23 |
| ALK | 2 | 1 |
| CS | ||
| IIIB–IIIC | 8 | 21 |
| IV | 10 | 52 |
| Treatment protocols | Performing salvage surgery after targeted therapy | Receiving targeted therapy only |
Abbreviations: ALK, anaplastic lymphoma kinase; CS, clinical stage.